1. |
|
|
2. |
- Stranne, Christian, et al.
(author)
-
Acoustic mapping of mixed layer depth
- 2018
-
In: Ocean Science. - : Copernicus GmbH. - 1812-0784 .- 1812-0792. ; 14:3, s. 503-514
-
Journal article (peer-reviewed)abstract
- The ocean surface mixed layer is a nearly universal feature of the world oceans. Variations in the depth of the mixed layer (MLD) influences the exchange of heat, fresh water (through evaporation), and gases between the atmosphere and the ocean and constitutes one of the major factors controlling ocean primary production as it affects the vertical distribution of biological and chemical components in near-surface waters. Direct observations of the MLD are traditionally made by means of conductivity, temperature, and depth (CTD) casts. However, CTD instrument deployment limits the observation of temporal and spatial variability in the MLD. Here, we present an alternative method in which acoustic mapping of the MLD is done remotely by means of commercially available ship-mounted echo sounders. The method is shown to be highly accurate when the MLD is well defined and biological scattering does not dominate the acoustic returns. These prerequisites are often met in the open ocean and it is shown that the method is successful in 95% of data collected in the central Arctic Ocean. The primary advantages of acoustically mapping the MLD over CTD measurements are (1) considerably higher temporal and horizontal resolutions and (2) potentially larger spatial coverage.
|
|
3. |
- Stranne, Johan, 1970, et al.
(author)
-
SPCG-15 : a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
- 2018
-
In: Scandinavian journal of urology. - : Medical Journals Sweden AB. - 2168-1805 .- 2168-1813. ; 52:5-6, s. 313-320
-
Journal article (peer-reviewed)abstract
- Objective: To describe study design and procedures for a prospective randomized trial investigating whether radical prostatectomy (RP) ± radiation improves cause-specific survival in comparison with primary radiation treatment (RT) and androgen deprivation treatment (ADT) in patients with locally advanced prostate cancer (LAPC).Materials and methods: SPCG-15 is a prospective, multi-centre, open randomized phase III trial. Patients are randomized to either standard (RT + ADT) or experimental (RP with extended pelvic lymph-node dissection and with addition of adjuvant or salvage RT and/or ADT if deemed necessary) treatment. Each centre follows guidelines regarding the timing and dosing of postoperative RT and adjuvant treatment such as ADT The primary endpoint is cause-specific survival. Secondary endpoints include metastasis-free and overall survival, quality-of-life, functional outcomes and health-services requirements. Each subject will be followed up for a minimum of 10 years.Results: Twenty-three centres in Denmark, Finland, Norway and Sweden, well established in performing RP and RT for prostate cancer participated. Each country’s sites were coordinated by national coordinating investigators and sub-investigators for urology and oncology. Almost 400 men have been randomized of the stipulated 1200, with an increasing rate of accrual.Conclusions: The SPCG-15 trial aims to compare the two curatively intended techniques supplying new knowledge to support future decisions in treatment strategies for patients with LAPC The Scandinavian healthcare context is well suited for performing multi-centre long-term prospective randomized clinical trials. Similar care protocols and a history of entirely tax-funded healthcare facilitate joint trials.
|
|